285 related articles for article (PubMed ID: 31379555)
1. Radiomic Features of the Nigrosome-1 Region of the Substantia Nigra: Using Quantitative Susceptibility Mapping to Assist the Diagnosis of Idiopathic Parkinson's Disease.
Cheng Z; Zhang J; He N; Li Y; Wen Y; Xu H; Tang R; Jin Z; Haacke EM; Yan F; Qian D
Front Aging Neurosci; 2019; 11():167. PubMed ID: 31379555
[No Abstract] [Full Text] [Related]
2. Imaging the Nigrosome 1 in the substantia nigra using susceptibility weighted imaging and quantitative susceptibility mapping: An application to Parkinson's disease.
Cheng Z; He N; Huang P; Li Y; Tang R; Sethi SK; Ghassaban K; Yerramsetty KK; Palutla VK; Chen S; Yan F; Haacke EM
Neuroimage Clin; 2020; 25():102103. PubMed ID: 31869769
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of Early-Stage Idiopathic Parkinson's Disease Using High-Resolution Quantitative Susceptibility Mapping Combined with Histogram Analysis in the Substantia Nigra at 3 T.
Kim EY; Sung YH; Shin HG; Noh Y; Nam Y; Lee J
J Clin Neurol; 2018 Jan; 14(1):90-97. PubMed ID: 29629545
[TBL] [Abstract][Full Text] [Related]
4. A preliminary attempt to visualize nigrosome 1 in the substantia nigra for Parkinson's disease at 3T: An efficient susceptibility map-weighted imaging (SMWI) with quantitative susceptibility mapping using deep neural network (QSMnet).
Jo M; Oh SH
Med Phys; 2020 Mar; 47(3):1151-1160. PubMed ID: 31883389
[TBL] [Abstract][Full Text] [Related]
5. The applied value in brain gray matter nuclei of patients with early-stage Parkinson's disease : a study based on multiple magnetic resonance imaging techniques.
Meng H; Zhang D; Sun Q
Head Face Med; 2023 Jun; 19(1):25. PubMed ID: 37386479
[TBL] [Abstract][Full Text] [Related]
6. MRI-Based Radiomics of Basal Nuclei in Differentiating Idiopathic Parkinson's Disease From Parkinsonian Variants of Multiple System Atrophy: A Susceptibility-Weighted Imaging Study.
Pang H; Yu Z; Li R; Yang H; Fan G
Front Aging Neurosci; 2020; 12():587250. PubMed ID: 33281598
[TBL] [Abstract][Full Text] [Related]
7. Diagnosing Parkinson's disease by combining neuromelanin and iron imaging features using an automated midbrain template approach.
Jokar M; Jin Z; Huang P; Wang Y; Zhang Y; Li Y; Cheng Z; Liu Y; Tang R; Shi X; Min J; Liu F; Chen S; He N; Haacke EM; Yan F
Neuroimage; 2023 Feb; 266():119814. PubMed ID: 36528314
[TBL] [Abstract][Full Text] [Related]
8. Imaging iron and neuromelanin simultaneously using a single 3D gradient echo magnetization transfer sequence: Combining neuromelanin, iron and the nigrosome-1 sign as complementary imaging biomarkers in early stage Parkinson's disease.
He N; Ghassaban K; Huang P; Jokar M; Wang Y; Cheng Z; Jin Z; Li Y; Sethi SK; He Y; Chen Y; Gharabaghi S; Chen S; Yan F; Haacke EM
Neuroimage; 2021 Apr; 230():117810. PubMed ID: 33524572
[TBL] [Abstract][Full Text] [Related]
9. Imaging of nigrosome 1 in substantia nigra at 3T using multiecho susceptibility map-weighted imaging (SMWI).
Nam Y; Gho SM; Kim DH; Kim EY; Lee J
J Magn Reson Imaging; 2017 Aug; 46(2):528-536. PubMed ID: 27859983
[TBL] [Abstract][Full Text] [Related]
10. Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping.
An H; Zeng X; Niu T; Li G; Yang J; Zheng L; Zhou W; Liu H; Zhang M; Huang D; Li J
J Neurol Sci; 2018 Mar; 386():46-52. PubMed ID: 29406966
[TBL] [Abstract][Full Text] [Related]
11. Multi-parametric radiomics of conventional T1 weighted and susceptibility-weighted imaging for differential diagnosis of idiopathic Parkinson's disease and multiple system atrophy.
Bu S; Pang H; Li X; Zhao M; Wang J; Liu Y; Yu H
BMC Med Imaging; 2023 Dec; 23(1):204. PubMed ID: 38066432
[TBL] [Abstract][Full Text] [Related]
12. Early-stage Parkinson's disease: Abnormal nigrosome 1 and 2 revealed by a voxelwise analysis of neuromelanin-sensitive MRI.
Sung YH; Noh Y; Kim EY
Hum Brain Mapp; 2021 Jun; 42(9):2823-2832. PubMed ID: 33751680
[TBL] [Abstract][Full Text] [Related]
13. Using 'swallow-tail' sign and putaminal hypointensity as biomarkers to distinguish multiple system atrophy from idiopathic Parkinson's disease: A susceptibility-weighted imaging study.
Wang N; Yang H; Li C; Fan G; Luo X
Eur Radiol; 2017 Aug; 27(8):3174-3180. PubMed ID: 28105503
[TBL] [Abstract][Full Text] [Related]
14. 3D texture analyses within the substantia nigra of Parkinson's disease patients on quantitative susceptibility maps and R2
Li G; Zhai G; Zhao X; An H; Spincemaille P; Gillen KM; Ku Y; Wang Y; Huang D; Li J
Neuroimage; 2019 Mar; 188():465-472. PubMed ID: 30578927
[TBL] [Abstract][Full Text] [Related]
15. Combining quantitative susceptibility mapping to radiomics in diagnosing Parkinson's disease and assessing cognitive impairment.
Kang JJ; Chen Y; Xu GD; Bao SL; Wang J; Ge M; Shen LH; Jia ZZ
Eur Radiol; 2022 Oct; 32(10):6992-7003. PubMed ID: 35461376
[TBL] [Abstract][Full Text] [Related]
16. Multiparametric MR imaging of Parkinsonisms at 3 tesla: Its role in the differentiation of idiopathic Parkinson's disease versus atypical Parkinsonian disorders.
Calloni SF; Conte G; Sbaraini S; Cilia R; Contarino VE; Avignone S; Sacilotto G; Pezzoli G; Triulzi FM; Scola E
Eur J Radiol; 2018 Dec; 109():95-100. PubMed ID: 30527319
[TBL] [Abstract][Full Text] [Related]
17. Iron quantification in Parkinson's disease using an age-based threshold on susceptibility maps: The advantage of local versus entire structure iron content measurements.
Sethi SK; Kisch SJ; Ghassaban K; Rajput A; Rajput A; Babyn PS; Liu S; Szkup P; Mark Haacke E
Magn Reson Imaging; 2019 Jan; 55():145-152. PubMed ID: 30321664
[TBL] [Abstract][Full Text] [Related]
18. Region-specific disturbed iron distribution in early idiopathic Parkinson's disease measured by quantitative susceptibility mapping.
He N; Ling H; Ding B; Huang J; Zhang Y; Zhang Z; Liu C; Chen K; Yan F
Hum Brain Mapp; 2015 Nov; 36(11):4407-20. PubMed ID: 26249218
[TBL] [Abstract][Full Text] [Related]
19. Quantitative Susceptibility Mapping-Derived Radiomic Features in Discriminating Multiple Sclerosis From Neuromyelitis Optica Spectrum Disorder.
Yan Z; Liu H; Chen X; Zheng Q; Zeng C; Zheng Y; Ding S; Peng Y; Li Y
Front Neurosci; 2021; 15():765634. PubMed ID: 34924934
[No Abstract] [Full Text] [Related]
20. Multimodal assessment of nigrosomal degeneration in Parkinson's disease.
Langley J; Huddleston DE; Crosson B; Song DD; Factor SA; Hu X
Parkinsonism Relat Disord; 2020 Nov; 80():102-107. PubMed ID: 32979784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
